{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:49:22Z","timestamp":1777675762908,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,20]],"date-time":"2027-03-20T00:00:00Z","timestamp":1805500800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jpet.2026.104311","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:57:17Z","timestamp":1772308637000},"page":"104311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Contextual Influences on Naltrexone Sensitization During Daily Morphine Exposure"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3203-1966","authenticated-orcid":false,"given":"Carol A.","family":"Paronis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)05224-3","article-title":"N-allylnormorphine: effects of single doses and precipitation of acute \"abstinence syndromes\" during addiction to morphine, methadone or heroin in man (post-addicts)","volume":"109","author":"Wikler","year":"1953","journal-title":"J Pharm Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-3565(25)30826-8","article-title":"A comparison of the effects of naloxone upon body weight and suppression of fixed-ratio operant behavior in morphine-dependent rats","volume":"201","author":"Gellert","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0091-3057(90)90269-N","article-title":"Opioid agonists\/antagonists in morphine-tolerant squirrel monkeys","volume":"36","author":"Dykstra","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)24746-2","article-title":"Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation","volume":"257","author":"Oliveto","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/jpet.110.173823","article-title":"Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal","volume":"336","author":"Paronis","year":"2011","journal-title":"J Pharm Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib6","first-page":"51","article-title":"The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state","volume":"17","author":"Valentino","year":"1981","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF00432222","article-title":"Behavioral effects of naloxone and nalorphine preceding and following morphine maintenance in the rhesus monkey","volume":"86","author":"Bergman","year":"1985","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(25)23975-1","article-title":"Effects of quaternary naltrexone and chlordiazepoxide in squirrel monkeys with enhanced sensitivty to the behavioral effects of naltrexone","volume":"235","author":"Warren","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00181944","article-title":"Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists","volume":"95","author":"Oliveto","year":"1988","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0022-3565(25)22842-7","article-title":"Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys","volume":"250","author":"France","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0022-3565(25)29030-9","article-title":"Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys","volume":"179","author":"Goldberg","year":"1971","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3565(25)23736-3","article-title":"Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone","volume":"248","author":"Warren","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0031-6997(25)06696-7","article-title":"Drug effects and the environmental control of behavior","volume":"27","author":"McKearney","year":"1976","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpet.2026.104311_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1749-6632.1992.tb25982.x","article-title":"Behavioral and pharmacological determinants of drug abuse","volume":"654","author":"Nader","year":"1992","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib15","first-page":"596","article-title":"Discriminative stimulus effects of naltrexone in the morphine-dependent rat","volume":"211","author":"Gellert","year":"1979","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-3565(25)22845-2","article-title":"Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys","volume":"250","author":"France","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-3565(25)30986-9","article-title":"Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys","volume":"202","author":"Spealman","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-3565(25)25080-7","article-title":"Modification of morphine tolerance by behavioral variables","volume":"237","author":"Sannerud","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-3565(25)24129-5","article-title":"Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys","volume":"248","author":"Bergman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpet.2026.104311_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-3565(25)20213-0","article-title":"Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule","volume":"252","author":"Craft","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-2999(89)90309-9","article-title":"Differential cross-tolerance to opioid agonists in morphine-tolerant squirrel monkeys responding under a schedule of food presentation","volume":"174","author":"Doty","year":"1989","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1139\/y79-014","article-title":"Effects of morphine, naloxone, and diallylnormorphine upon behaviour maintained by electric-shock postponement in squirrel monkeys","volume":"57","author":"Stretch","year":"1979","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(25)39099-3","article-title":"Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration","volume":"242","author":"Gmerek","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0022-3565(25)11236-6","article-title":"Agonist and antagonist activity opf kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment","volume":"260","author":"Craft","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2026.104311_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(87)91571-X","article-title":"Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists","volume":"436","author":"Shippenberg","year":"1987","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.jpet.2026.104311_bib27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2826.2001.00713.x","article-title":"Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm","volume":"13","author":"Houshyar","year":"2001","journal-title":"J Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.jpet.2026.104311_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00006842-197511000-00005","article-title":"Effects of acute exposure to stressors on subsequent avoidance-escape behavior","volume":"37","author":"Weiss","year":"1975","journal-title":"Psychsom Med"},{"issue":"4","key":"10.1016\/j.jpet.2026.104311_bib29","first-page":"708","article-title":"Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys","volume":"23","author":"Williams","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104311_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02243995","article-title":"Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats","volume":"100","author":"Adams","year":"1990","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104311_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-3565(24)36771-0","article-title":"Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal","volume":"282","author":"Paronis","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:16:30Z","timestamp":1777450590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526005100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0022356526005100"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104311","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contextual Influences on Naltrexone Sensitization During Daily Morphine Exposure","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104311"}}